Search Results
61 items found for "therapy"
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
Axis by Repurposing Vaptans "Men with advanced prostate cancer are treated by androgen deprivation therapy
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Disease Antiverse, Nxera Pharma Teams to Unleash Machine Learning on Elusive Biological Keys to Medical Therapies Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
GPR35 ligands that selectively modulate GPR35-transducer interactions and allow for mechanism-based therapies
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
- GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS
opportunities in the translational development of these findings to generate safe and effective precision therapies
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Therefore, a better understanding of the pathophysiology of hepatic fibrosis and the development of related therapies
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
key biological process but also provides a valuable map for pharmaceutical researchers to design new therapies
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Wins Biotech Company of the Year and Financing Deal of the Year at the Citeline Japan Awards 2024 GPCR therapies
- 📰 GPCR Weekly News - January 2 to 8, 2023
Collaboration for Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies
- 📰 GPCR Weekly News, January 16 to 22, 2023
Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech is attending the 3rd Advanced Therapy
- Exploring the Breakthroughs in GPCR Research
the basics covered in Course I, this course explores advanced methods in GPCR utilization for drug therapy
- 📰 GPCR Weekly News, December 4 to 10, 2023
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion FDA approves two gene therapies
- 📰 GPCR Weekly News, June 24 to 30, 2024
Immunology Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Respiratory infections predominate after day 100 following B-cell maturation antigen-directed CAR T-cell therapy
- From DNA day to GPCR genomics
bioinformatics, and clinical research has opened new avenues for exploring GPCR biology, developing targeted therapies
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease therapy
- 📰 GPCR Weekly News, November 20 to 26, 2023
conservation across distant species Industry News Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy
- 📰 GPCR Weekly News, November 13 to 19, 2023
structural dynamics approach for identification of potential agonists of FFAR4 for type 2 diabetes mellitus therapy
- 📰 GPCR Weekly News, May 27 to June 2, 2024
concentrations in Caenorhabditis elegans Comparison of infectious complications with BCMA-directed therapies
- 📰 GPCR Weekly News, March 13 to 19, 2023
Drug Hunter GPCR Therapeutics Announces Publication in Nature Scientific Reports on Novel Anticancer Therapy
- 📰 GPCR Weekly News, February 20 to 26, 2023
Cell-trafficking impairment in disease-associated LPA6 missense mutants and a potential pharmacoperone therapy
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Discovery Flavors of GPCR signaling bias Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
- 📰 GPCR Weekly News, January 22 to 28, 2024
Sosei Heptares Webinar Presentation for FY2023 Financial Results Novartis Automates New Radioligand Therapy
- 📰 GPCR Weekly News, July 1 to 7, 2024
continues with the basics learned in Course 1 and extends the ideas to apply GPCR utilization in drug therapy
- 📰 GPCR Weekly News, June 17 to 23, 2024
against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease therapy
- 📰 GPCR Weekly News, December 11 to 17, 2023
Proof-of-Concept Data From Phase 2a Clinical Study Neurocrine opening two Phase 1 trials in oral Parkinson’s therapies
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for cancer therapy